Literature DB >> 23774529

Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.

Richard A Sturm1, Carly Fox2, Phil McClenahan3, Kasturee Jagirdar4, Maider Ibarrola-Villava5, Parastoo Banan6, Nicola C Abbott6, Gloria Ribas7, Brian Gabrielli2, David L Duffy8, H Peter Soyer6.   

Abstract

A germline polymorphism of the microphthalmia transcription factor (MITF) gene encoding a SUMOylation-deficient E318K-mutated protein has recently been described as a medium-penetrance melanoma gene. In a clinical assessment of nevi from 301 volunteers taken from Queensland, we identified six individuals as MITF E318K mutation carriers. The phenotype for 5 of these individuals showed a commonality of fair skin, body freckling that varied over a wide range, and total nevus count between 46 and 430; in addition, all were multiple primary melanoma patients. The predominant dermoscopic signature pattern of nevi was reticular, and the frequency of globular nevi in carriers varied, which does not suggest that the MITF E318K mutation acts to force the continuous growth of nevi. Excised melanocytic lesions were available for four MITF E318K carrier patients and were compared with a matched range of wild-type (WT) melanocytic lesions. The MITF staining pattern showed a predominant nuclear signal in all sections, with no significant difference in the nuclear/cytoplasmic ratio between mutation-positive or -negative samples. A high incidence of amelanotic melanomas was found within the group, with three of the five melanomas from one patient suggesting a genetic interaction between the MITF E318K allele and an MC1R homozygous red hair color (RHC) variant genotype.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774529     DOI: 10.1038/jid.2013.272

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  42 in total

1.  A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.

Authors:  Corine Bertolotto; Fabienne Lesueur; Sandy Giuliano; Thomas Strub; Mahaut de Lichy; Karine Bille; Philippe Dessen; Benoit d'Hayer; Hamida Mohamdi; Audrey Remenieras; Eve Maubec; Arnaud de la Fouchardière; Vincent Molinié; Pierre Vabres; Stéphane Dalle; Nicolas Poulalhon; Tanguy Martin-Denavit; Luc Thomas; Pascale Andry-Benzaquen; Nicolas Dupin; Françoise Boitier; Annick Rossi; Jean-Luc Perrot; Bruno Labeille; Caroline Robert; Bernard Escudier; Olivier Caron; Laurence Brugières; Simon Saule; Betty Gardie; Sophie Gad; Stéphane Richard; Jérôme Couturier; Bin Tean Teh; Paola Ghiorzo; Lorenza Pastorino; Susana Puig; Celia Badenas; Hakan Olsson; Christian Ingvar; Etienne Rouleau; Rosette Lidereau; Philippe Bahadoran; Philippe Vielh; Eve Corda; Hélène Blanché; Diana Zelenika; Pilar Galan; François Aubin; Bertrand Bachollet; Céline Becuwe; Pascaline Berthet; Yves Jean Bignon; Valérie Bonadona; Jean-Louis Bonafe; Marie-Noëlle Bonnet-Dupeyron; Fréderic Cambazard; Jacqueline Chevrant-Breton; Isabelle Coupier; Sophie Dalac; Liliane Demange; Michel d'Incan; Catherine Dugast; Laurence Faivre; Lynda Vincent-Fétita; Marion Gauthier-Villars; Brigitte Gilbert; Florent Grange; Jean-Jacques Grob; Philippe Humbert; Nicolas Janin; Pascal Joly; Delphine Kerob; Christine Lasset; Dominique Leroux; Julien Levang; Jean-Marc Limacher; Cristina Livideanu; Michel Longy; Alain Lortholary; Dominique Stoppa-Lyonnet; Sandrine Mansard; Ludovic Mansuy; Karine Marrou; Christine Matéus; Christine Maugard; Nicolas Meyer; Catherine Nogues; Pierre Souteyrand; Laurence Venat-Bouvet; Hélène Zattara; Valérie Chaudru; Gilbert M Lenoir; Mark Lathrop; Irwin Davidson; Marie-Françoise Avril; Florence Demenais; Robert Ballotti; Brigitte Bressac-de Paillerets
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

2.  Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.

Authors:  A E Thurber; G Douglas; E C Sturm; S E Zabierowski; D J Smit; S N Ramakrishnan; E Hacker; J H Leonard; M Herlyn; R A Sturm
Journal:  Oncogene       Date:  2011-02-28       Impact factor: 9.867

3.  IRF4 variants have age-specific effects on nevus count and predispose to melanoma.

Authors:  David L Duffy; Mark M Iles; Dan Glass; Gu Zhu; Jennifer H Barrett; Veronica Höiom; Zhen Z Zhao; Richard A Sturm; Nicole Soranzo; Chris Hammond; Marina Kvaskoff; David C Whiteman; Massimo Mangino; Johan Hansson; Julia A Newton-Bishop; Veronique Bataille; Nicholas K Hayward; Nicholas G Martin; D Timothy Bishop; Timothy D Spector; Grant W Montgomery
Journal:  Am J Hum Genet       Date:  2010-06-17       Impact factor: 11.025

4.  Dermoscopy, reflectance confocal microscopy and histopathology of an amelanotic melanoma from an individual heterozygous for MC1R and tyrosinase variant alleles.

Authors:  Claudia Curchin; Elisabeth Wurm; Kasturee Jagirdar; Richard Sturm; Peter Soyer
Journal:  Australas J Dermatol       Date:  2012-04-12       Impact factor: 2.875

5.  Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma.

Authors:  Scott R Granter; Katherine N Weilbaecher; Catherine Quigley; David E Fisher
Journal:  Appl Immunohistochem Mol Morphol       Date:  2002-03

6.  CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.

Authors:  L Pastorino; L Bonelli; P Ghiorzo; P Queirolo; L Battistuzzi; E Balleari; S Nasti; S Gargiulo; S Gliori; P Savoia; S Abate Osella; M G Bernengo; G Bianchi Scarrà
Journal:  Pigment Cell Melanoma Res       Date:  2008-10-22       Impact factor: 4.693

7.  Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.

Authors:  F Cuéllar; S Puig; I Kolm; J Puig-Butille; P Zaballos; R Martí-Laborda; C Badenas; J Malvehy
Journal:  Br J Dermatol       Date:  2008-09-15       Impact factor: 9.302

8.  The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures.

Authors:  Amanda J Baxter; Maria Celia Hughes; Marina Kvaskoff; Victor Siskind; Sri Shekar; Joanne F Aitken; Adele C Green; David L Duffy; Nicholas K Hayward; Nicholas G Martin; David C Whiteman
Journal:  Twin Res Hum Genet       Date:  2008-04       Impact factor: 1.587

9.  Analysis of cultured human melanocytes based on polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P loci.

Authors:  Anthony L Cook; Wei Chen; Amy E Thurber; Darren J Smit; Aaron G Smith; Timothy G Bladen; Darren L Brown; David L Duffy; Lorenza Pastorino; Giovanna Bianchi-Scarra; J Helen Leonard; Jennifer L Stow; Richard A Sturm
Journal:  J Invest Dermatol       Date:  2008-07-24       Impact factor: 8.551

10.  A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).

Authors:  Mark Harland; Alisa M Goldstein; Kairen Kukalizch; Claire Taylor; David Hogg; Susana Puig; Celia Badenas; Nelleke Gruis; Jeanet ter Huurne; Wilma Bergman; Nicholas K Hayward; Mitchell Stark; Hensin Tsao; Margaret A Tucker; Maria Teresa Landi; Giovanna Bianchi Scarra; Paola Ghiorzo; Peter A Kanetsky; David Elder; Graham J Mann; Elizabeth A Holland; D Timothy Bishop; Julia Newton Bishop
Journal:  Eur J Cancer       Date:  2008-04-03       Impact factor: 9.162

View more
  21 in total

1.  Non-reproducible sequence artifacts in FFPE tissue: an experience report.

Authors:  Richard Ofner; Cathrin Ritter; Selma Ugurel; Lorenzo Cerroni; Mathias Stiller; Thomas Bogenrieder; Flavio Solca; David Schrama; Jürgen C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-17       Impact factor: 4.553

Review 2.  Molecular pathology of cutaneous melanoma.

Authors:  Léon C van Kempen; Margaret Redpath; Caroline Robert; Alan Spatz
Journal:  Melanoma Manag       Date:  2014-12-04

Review 3.  Update in genetic susceptibility in melanoma.

Authors:  Miriam Potrony; Celia Badenas; Paula Aguilera; Joan Anton Puig-Butille; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Ann Transl Med       Date:  2015-09

Review 4.  Pro-survival role of MITF in melanoma.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  J Invest Dermatol       Date:  2014-08-21       Impact factor: 8.551

Review 5.  Pathways from senescence to melanoma: focus on MITF sumoylation.

Authors:  J Leclerc; R Ballotti; C Bertolotto
Journal:  Oncogene       Date:  2017-08-21       Impact factor: 9.867

Review 6.  Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling.

Authors:  Efthymia Soura; Philip J Eliades; Kristen Shannon; Alexander J Stratigos; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2016-03       Impact factor: 11.527

7.  Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.

Authors:  Steven Vernali; Weston T Waxweiler; Patrick M Dillon; Peter A Kanetsky; Irene Orlow; Li Luo; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  JAMA Dermatol       Date:  2017-10-01       Impact factor: 10.282

8.  Deregulated MITF sumoylation: A route to melanoma.

Authors:  Robert Ballotti; Corine Bertolotto
Journal:  Mol Cell Oncol       Date:  2017-05-26

Review 9.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

10.  Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC).

Authors:  I Orlow; J M Satagopan; M Berwick; H L Enriquez; K A M White; K Cheung; S W Dusza; S A Oliveria; M A Marchetti; A Scope; A A Marghoob; A C Halpern
Journal:  Br J Dermatol       Date:  2015-02-15       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.